2025 · 3rd Quarter (July 1 - Sep 30)

TERUMO BCT, INC.

Filed by TERUMO BCT, INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 21, 2025
Income: Not reported
Expenses: $20,000.00
Registrant: TERUMO BCT, INC.
Client: TERUMO BCT, INC.
Filing UUID: 856dda45-cdf3-470f-ab12-65f3900aa008
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Global trade and tariffs

HCR · Health Issues

S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality

Literal federal measure citations: S.721, S.752, H.R.1509, S.735, H.R. 1796

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.